AU2003240730A1 - Morpholinylmethylureas ccr-3 receptor antagonist - Google Patents

Morpholinylmethylureas ccr-3 receptor antagonist

Info

Publication number
AU2003240730A1
AU2003240730A1 AU2003240730A AU2003240730A AU2003240730A1 AU 2003240730 A1 AU2003240730 A1 AU 2003240730A1 AU 2003240730 A AU2003240730 A AU 2003240730A AU 2003240730 A AU2003240730 A AU 2003240730A AU 2003240730 A1 AU2003240730 A1 AU 2003240730A1
Authority
AU
Australia
Prior art keywords
morpholinylmethylureas
ccr
receptor antagonist
antagonist
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003240730A
Inventor
Caroline Mary Cook
Colin David Eldred
Lee Andrew Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003240730A1 publication Critical patent/AU2003240730A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003240730A 2002-05-29 2003-05-26 Morpholinylmethylureas ccr-3 receptor antagonist Abandoned AU2003240730A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0212357.8A GB0212357D0 (en) 2002-05-29 2002-05-29 Novel compounds
GB0212357.8 2002-05-29
PCT/EP2003/005597 WO2003099798A1 (en) 2002-05-29 2003-05-26 Morpholinylmethylureas ccr-3 receptor antagonist

Publications (1)

Publication Number Publication Date
AU2003240730A1 true AU2003240730A1 (en) 2003-12-12

Family

ID=9937626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003240730A Abandoned AU2003240730A1 (en) 2002-05-29 2003-05-26 Morpholinylmethylureas ccr-3 receptor antagonist

Country Status (3)

Country Link
AU (1) AU2003240730A1 (en)
GB (1) GB0212357D0 (en)
WO (1) WO2003099798A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN03493A (en) 2004-09-08 2015-07-03 Mitsubishi Tanabe Pharma Corp
ES2764840T3 (en) 2015-01-28 2020-06-04 Univ Bordeaux Use of plerixafor to treat and / or prevent acute exacerbations of chronic obstructive pulmonary disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69527786T2 (en) * 1994-05-18 2003-04-10 Nisshin Seifun Group Inc., Tokio/Tokyo DIAMINOMETHYLIDEN DERIVATIVES
EP1187810A2 (en) * 1999-05-25 2002-03-20 Sepracor, Inc. Heterocyclic analgesic compounds and their use
CA2423305A1 (en) * 2000-09-29 2002-04-04 Glaxo Group Limited Compounds useful in the treatment of inflammatory diseases
CZ20031195A3 (en) * 2000-09-29 2003-09-17 Glaxo Group Limited Morpholinoacetamide derivatives

Also Published As

Publication number Publication date
GB0212357D0 (en) 2002-07-10
WO2003099798A8 (en) 2004-01-15
WO2003099798A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2003231513A1 (en) Pgd2 receptor antagonist
AU2003261392A1 (en) M3muscarinic acetylcholine receptor antagonists
HK1129893A1 (en) Tricyclic thrombin receptor antagonist
AU2003241836A1 (en) Lpa receptor antagonists
EP1576112A3 (en) Cytokine receptor zcytor17 multimers
IL165841A0 (en) Mchir antagonists
AU2003301851A1 (en) Azacyclic compounds as orexin receptor antagonist
AUPR833401A0 (en) G protein-coupled receptor antagonists
AU2003255501A1 (en) Cxcr4 receptor antagonists
PL378753A1 (en) Ccr-3 receptor antagonists
AU2003291959A1 (en) Novel glucagon antagonists
IL164016A0 (en) Azetidine derivatives as ccr-3 receptor antagonists
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2003267088A1 (en) Chemokine receptor antagonists as therapeutic agents
AU2003236247A1 (en) Bombesin antagonists
IL165727A0 (en) Chemokine antagonists
AU2003240705A1 (en) Morpholinylmethylureas ccr-3 receptor antagonists
AU2003300904A1 (en) Antagonists for human prolactin
AU2003277552A1 (en) Receptor regulator
AU2003248356A1 (en) Beta3-adrenergic receptor agonists
AU2003242506A1 (en) Tf antagonist
AU2003287219A1 (en) Il-8 receptor antagonists
PL370367A1 (en) Ccr-3 receptor antagonists v
PL373275A1 (en) Ccr-3 receptor antagonists vii
AU2003240730A1 (en) Morpholinylmethylureas ccr-3 receptor antagonist

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase